PLRX — Pliant Therapeutics Share News
0.000.00%
Last trade - 00:00- $50.52m
- -$107.59m
Pliant Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Pliant Therapeutics Q2 Net Income USD -43.3 Million
Pliant Therapeutics Inc expected to post a loss of 70 cents a share - Earnings Preview
Pliant Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Pliant Therapeutics Q1 Net Income USD -56.166 Million
Pliant Therapeutics Inc expected to post a loss of 72 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-California Resources, Eli Lilly, Mastec
Brief: Pliant Therapeutics Q4 Net Income USD -49.732 Million
U.S. STOCKS ON THE MOVE-THOR Industries, TG Therapeutics, Target
Pliant touches record low after scrapping trial of lung-disease drug
Brief: Pliant Therapeutics Provides Update On Beacon-IPF
U.S. STOCKS ON THE MOVE-Nike, WesBanco, Monday.Com
Pliant Therapeutics slumps after company halts enrollment in mid-stage trial of lung disease drug
U.S. STOCKS ON THE MOVE-NXP Semiconductors, Oil stocks, Mobileye
U.S. STOCKS ON THE MOVE-Reddit, Rockwell Automation, NXP Semiconductors
U.S. STOCKS ON THE MOVE-McDonald's, T-Mobile, Gold miners
Pliant Therapeutics slumps as it halts enrollment in lung disease mid-stage trial
Pliant pauses enrollment for lung disease treatment trial
Brief: Pliant Therapeutics Provides Update On BEACON-IPF, A Phase 2B/3 Trial In Patients With Idiopathic Pulmonary Fibrosis